PSMA-ALB-56

Modify Date: 2024-04-09 18:00:31

PSMA-ALB-56 structure	Common Name	PSMA-ALB-56
	CAS Number	2306049-48-7	Molecular Weight	1330.52
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₆₆H₉₅N₁₁O₁₈	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of PSMA-ALB-56

PSMA-ALB-56 is a PSMA-targeting radioligand designed by combining the glutamate-urea PSMA-binding entity and an albumin binder[1].

Name	PSMA-ALB-56

Description	PSMA-ALB-56 is a PSMA-targeting radioligand designed by combining the glutamate-urea PSMA-binding entity and an albumin binder[1].
Related Catalog	Research Areas >> Cancer
Target	Traditional Cytotoxic Agents
In Vivo	PSMA-ALB-56 accumulates much faster in tumor tissues and is more efficiently cleared from the blood and background tissues, which results in excellent tumor-to-background contrast already 4 hours after injection. PSMA-ALB-56 increases median survival in mice[1].
References	[1]. Umbricht CA, et al. Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy. Mol Pharm. 2018;15(6):2297-2306.

Molecular Formula	C₆₆H₉₅N₁₁O₁₈
Molecular Weight	1330.52